Literature DB >> 27467044

Microsporidial Stromal Keratitis: Clinical Features, Unique Diagnostic Criteria, and Treatment Outcomes in a Large Case Series.

Swapnali Sabhapandit1, Somasheila I Murthy, Prashant Garg, Veeresh Korwar, Geeta K Vemuganti, Savitri Sharma.   

Abstract

PURPOSE: To describe the history, clinical features, and outcomes of a large case series of microsporidial stromal keratitis with emphasis on probable predictors of the etiology in this rare and unspecified form of keratitis.
METHODS: Retrospective analysis of cases seen between January, 2002, and December, 2013, diagnosed at LV Prasad Eye Institute as having microsporidial stromal keratitis based on clinical, microbiology, and histopathology examination. Outcomes of medical and surgical management with visual recovery were documented.
RESULTS: There were 34 cases of microsporidial stromal keratitis with a mean age of 43.3 years (range 2-77 years) and male preponderance. The duration of symptoms was chronic in most cases (mean duration of 288 days). Nearly half of the cases had a history of trauma, in the age group of 20 to 50 years. The most common clinical misdiagnosis was herpes simplex virus keratitis (26.5%) followed by fungal keratitis (17.6%). This could be attributed to the nonspecific clinical picture of diffuse multifocal stromal lesions in 82.4% of cases. The organisms were detected in microbiological evaluation of corneal scrapings in 47% cases, and histopathological detection of the organisms showed a positivity rate of 92.3%. Surgical management was necessary in the majority of the cases (73.5% of patients).
CONCLUSIONS: The typical history of trauma with a smoldering, diffuse form of keratitis refractory to conventional medical therapy, responding to surgical removal for recovery is clearly demonstrated as a recurring feature in the majority of the cases. Patients presenting with this characteristic clinical picture should be suspected to harbor this rare pathogen, and early surgical interventions should be considered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27467044     DOI: 10.1097/ICO.0000000000000939

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Demographic and clinical profile of microspodial keratitis in North India: an underreported entity.

Authors:  Sumeeta Khurana; Sonu Kumari Agrawal; Kirti Megha; Sujata Dwivedi; Neha Jain; Amit Gupta
Journal:  J Parasit Dis       Date:  2019-06-15

2.  Stromal microsporidiosis: a differential for disciform keratitis.

Authors:  Anirban Dutta; Sujata Das; Smruti Rekha Priyadarshini
Journal:  BMJ Case Rep       Date:  2020-09-07

3.  Tectonic Deep Anterior Lamellar Keratoplasty to Treat Corneal Perforation and Descemetocele from Microbial Keratitis.

Authors:  Hong The Nguyen; Ngoc Dong Pham; Tung Quoc Mai; Hang Thi Thuy Do; Duong Thi Nga Nguyen; Peter McCluskey; Trong Van Pham
Journal:  Clin Ophthalmol       Date:  2021-08-24

Review 4.  Infectious keratitis: A review.

Authors:  Maria Cabrera-Aguas; Pauline Khoo; Stephanie L Watson
Journal:  Clin Exp Ophthalmol       Date:  2022-06-03       Impact factor: 4.383

Review 5.  A Narrative Review of Microsporidial Infections of the Cornea.

Authors:  Majid Moshirfar; Shaan N Somani; Kathryn M Shmunes; Ladan Espandar; Nikhil S Gokhale; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Ophthalmol Ther       Date:  2020-03-10

6.  Acute stromal keratitis in clinics - are we missing microsporidia?

Authors:  Javed Hussain Farooqui; Manisha Acharya; Arpan Gandhi; Umang Mathur
Journal:  GMS Ophthalmol Cases       Date:  2020-02-14

7.  Microsporidial stromal keratitis in an immunocompromised patient: Successful management with medical therapy.

Authors:  Amanjot Kaur; Srikant K Sahu; Sanchita Mitra; Sujata Das
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

8.  Stromal microsporidial keratitis successfully treated with medical therapy.

Authors:  Christopher P Donovan; Curtis E Margo; Edgar M Espana
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.